Kwan Y. Hui

Eli Lilly (United States) — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

13h-index966citations23works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Receptor Mechanisms and Signaling(5), HIV/AIDS drug development and treatment(4), Renin-Angiotensin System Studies(4), HIV Research and Treatment(3), Cell Adhesion Molecules Research(3)

Publications23 total

Chemical analysis of atherosclerotic plaque cholesterol combined with histology of the same tissue
Journal of Lipid Research·2008· 15 citedOpen Access
Genetic ablation of IRAK4 kinase activity inhibits vascular lesion formation
Biochemical and Biophysical Research Communications·2008· 42 cited
Circulating Markers Reflect Both Anti- and Pro-Atherogenic Drug Effects in ApoE-Deficient Mice
Biomarker Insights·2008· 1 citedOpen Access
High-Resolution Quantitative Computed Tomography Demonstrating Selective Enhancement of Medium-Size Collaterals by Placental Growth Factor-1 in the Mouse Ischemic Hindlimb
Circulation·2006· 35 citedOpen Access
Toward a universal inhibitor of retroviral proteases: Comparative analysis of the interactions of LP‐130 complexed with proteases from HIV‐1, FIV, and EIAV
Protein Science·1998· 35 citedOpen Access
Differential Activation of Cytosolic Phospholipase A2 (cPLA2) by Thrombin and Thrombin Receptor Agonist Peptide in Human Platelets. EVIDENCE FOR ACTIVATION OF cPLA2 INDEPENDENT OF THE MITOGEN-ACTIVATED PROTEIN KINASES ERK1/2
Journal of Biological Chemistry·1995· 125 citedOpen Access
Structure of an inhibitor complex of the proteinase from feline immunodeficiency virus
Nature Structural & Molecular Biology·1995· 62 cited
Model peptides to study the effects of P<sub>2</sub> and P<sub>3</sub> substitutions in statine‐containing HIV proteinase inhibitors
FEBS Letters·1993· 8 citedOpen Access
Minimal sequence requirement of thrombin receptor agonist peptide
Biochemical and Biophysical Research Communications·1992· 89 cited
Angiotensin I and II disappear completely from circulating blood within 48 hours after binephrectomy
Journal of Hypertension·1991· 5 cited
A rational approach in the search for potent inhibitors against HIV proteinase
The FASEB Journal·1991· 15 cited
Characterization of prorenin activation using a synthetic peptide substrate
Journal of Hypertension·1991· 8 cited
Angiotensin I and II disappear completely from circulating blood within 48 hours after binephrectomy
Journal of Hypertension·1991· 1 cited
Serine and<scp>d</scp>‐serine position‐1 substituted angiotensin II analogues Synthesis using new 2,3,5,6‐tetrafluorophenyl active esters and biological activities
International journal of peptide & protein research·1989· 5 cited
Design of rat renin inhibitory peptides
Journal of Medicinal Chemistry·1988· 24 citedOpen Access
Protected amino acid tetrafluorophenyl esters for peptide synthesis
International journal of peptide & protein research·1988· 11 cited
Analysis of structure-activity relationships in renin substrate analog inhibitory peptides
Journal of Medicinal Chemistry·1987· 26 citedOpen Access
Renin Inhibitors
Journal of Cardiovascular Pharmacology·1987· 11 cited
A Monoclonal Antibody Specific for the Amino Terminal Sequence of Human Prorenin Identifies a Common Epitope on Renal and Amniotic Fluid Inactive Renins
Journal of Hypertension·1986· 6 cited
Antibody-Directed Urokinase: A Specific Fibrinolytic Agent
Science·1985· 155 cited
page 1 of 2Next →

Frequent Co-authors

Edgar Haber(7), Gary R. Matsueda(3), Eddie L. Angleton(3), Mark D. Rekhter(3), Pamela Rutherford(3), Donetta S. Gifford‐Moore(3), Xiaodi Huang(3), William D. Carlson(3), Joseph A. Jakubowski(2), Alexander Wlodawer(2), Alla Gustchina(2), J. Łubkowski(2), Alexander Zdanov(2), Deepa Bhatt(2), Ben M. Dunn(2), Nancy K Jackson(2), Ming‐Shang Kuo(2), Michael S. Bernatowicz(2), Kenneth E. Gould(2), Joseph Manetta(2)